Articles

Learning from Leaders: Competitive Intelligence in Health & Life Sciences

Posted by | Fuld & Company

 

In response to the economic downturn, supply chain disruption, and geopolitical tensions, companies are increasingly relying on competitive intelligence and research.

Our recent webinar provided critical insights into maximizing your competitive advantage in the rapidly changing landscape of the Health & Life Sciences sector. Industry leaders shared their expertise, best practices, and future perspectives on competitive intelligence (CI) in this exclusive event.

 

Watch the recording:

2

 

Webinar highlights

1. Harnessing Competitive Intelligence for Success in Health & Life Sciences

In the dynamic realm of the health and life sciences sector, the effective utilization of competitive intelligence plays a crucial role in achieving success. In our recent webinar Fuld’s COO Michele Sachar, was joined by Maura Buxton, Director of Enterprise Market Strategy at CVS Health; Lindsay Green, Market Research Consultant at CareFirst Blue Cross Blue Shield; and Brad Thompson, an industry expert with experience at Pfizer and Merck to discuss their strategies and ideas for gathering, analyzing and leveraging competitive intelligence.

2. Navigating the Complexities of the Healthcare Industry

Staying ahead of macro forces such as digital innovation, industry consolidation, and the emergence of new market players can provide organizations with a competitive advantage. By challenging traditional notions of competitors and adopting a broader perspective, innovative partnerships and opportunities can be uncovered.

3. Adapting to the COVID-19 Pandemic

The COVID-19 pandemic has significantly reshaped the landscape of the health and life sciences industry and, consequently, the practice of competitive intelligence. Real-time insights and dynamic decision-making have become imperative to navigate policy changes, vaccine development, and market fluctuations. In response to the rapid changes brought about by the pandemic, proactive competitive intelligence strategies are now more critical than ever to keep ahead, enabling organizations to anticipate and adapt to rapid shifts, including the rise of telemedicine, mental health services, and disruptive technologies.

4. Leveraging the Power of Artificial Intelligence (AI)

In the era of digital transformation, artificial intelligence (AI) has emerged as a game-changer in competitive intelligence practices. Leveraging AI tools and technologies enables organizations to gather and analyze vast amounts of data, resulting in deeper insights and enhanced accuracy and efficiency. However, it is crucial to strike a balance between AI-driven insights and the value of human expertise, qualitative discussions, and networking to drive competitive advantage.

5. AI Tools and Applications for Competitive Intelligence

AI tools such as web crawlers and media monitoring platforms have become indispensable for data gathering and analysis within health and life sciences. Moreover, the applications of generative AI in health insurance processes, such as claims processing and prior authorization, have streamlined operations, increased efficiency, and reduced administrative burdens. Organizations that embrace these AI tools gain a competitive edge, fostering innovation within their operations.

6. Understanding the Implications of Healthcare AI Investments

The increasing interest and investment in healthcare AI have significant implications for competitive intelligence professionals. Established companies are incorporating AI into their technologies, reshaping the industry landscape, and presenting both challenges and opportunities. Staying well-informed and adapting strategies accordingly is vital in this rapidly evolving landscape and capitalizing on emerging trends and developments.

7. Driving Strategic Decision-Making

Looking ahead, accurate forecasting and optimal resource allocation will be crucial for maintaining a competitive edge. Contextual understanding, comprehensive competitor analysis, and gathering insights from thought leaders and industry events will play a pivotal role in strategic decision-making. Demonstrating the value and return on investment of competitive intelligence will be essential, aligning the intelligence process with organizational goals and objectives.

Conclusion

Competitive intelligence is the key to success in the fast-paced and fiercely competitive health and life sciences sector. By staying attuned to market trends, expanding our perspective on competitors, and embracing the potential of AI while valuing human insights and connectivity, we can drive organizations toward greater growth, innovation, and triumph in an increasingly challenging landscape.

Meet our Panelists:

Michele Sachar
COO
Fuld & Company
Maura Buxton
Director of Enterprise Market Strategy
CVS Health
Lindsie Green
Lead Consultant, Customer Insights
CareFirst, BlueCross BlueShield
Brad Thompson
Consultant, Commercial Strategic Development, Vaccines
Former commercial leader at Merck and Pfizer

Tags: , , , , ,

Related Resources

Read More

Leveraging Research & Analytics in boutique investment banks

In today’s dynamic financial landscape, boutique investment banks face the dual challenge of accelerating deal flow while simultaneously modernizing operations […]

Read More

Webinar: Mastering Dealmaking Tools… to close deals faster and more efficiently

In today’s dynamic dealmaking landscape, successfully leveraging Research & Analytics can be the key differentiator for boutique Investment Banks. Our […]

Read More

The AI revolution: Transforming private investments

In recent years, the surge of Artificial Intelligence (AI) has brought about a significant change in the world of private […]

Subscribe to our mailing list for our latest updates: